We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Proactis Holdings Plc | LSE:PHD | London | Ordinary Share | GB00B13GSS58 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 74.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
03/5/2018 11:51 | 4 Directors bought shares at 155p on 13th March. Given current year is transformative, adjusted EPS for 2019 is 11.6p according to Progressive Equity Research. At 102p shares are on 2019 PER of 8.8x. IMHO share price is unattractive short term but will recover strongly at some stage next year. GLA | chasbas | |
03/5/2018 11:32 | There is a significant sell or overhang, just purchased £10ks worth, in 4 tranches each time the offer reduced. Just tried a dummy £22.5K buy and offer is 101.6p WTF... Game on. | cantrememberthis2 | |
01/5/2018 16:18 | Charts seem to like round numbers Hence 100p looks a likely test stopping off point for now | buywell3 | |
01/5/2018 16:15 | Mine is at the bottom, lol. 2018-05-01 16:12:09 109.00 50,000 ? 54,500 O 2018-05-01 16:12:00 109.00 25,000 ? 27,250 O 2018-05-01 16:12:00 109.00 25,000 ? 27,250 O 2018-05-01 16:10:23 109.20 2,283 Buy 2,493 O | alamaison5 | |
30/4/2018 14:00 | PHD management are presenting at a London investor event on Monday 11th June, 5pm. The event is hosted by Progressive Equity Research and piworld. If you'd like to attend, please let us know through piworld.co.uk - the contact form. (There will be 3 companies in total: Hardide, plus one other) | tomps2 | |
26/4/2018 12:25 | Adding. Let's see what the next 12-24 months bring and will then have a clearer idea what is right and wrong. | p1nkfish | |
26/4/2018 11:36 | last 5-7 posts look a bit desperate imo if PHD offerring is so wonderful and beneficial for clients and potential clients pls explain the disastrous organic growth of 3% !! & why 4 big clients left imo either 'you' are wrong or the 3% organic growth rate is wrong ! | smithie6 | |
25/4/2018 22:28 | Another thing - analytics. Analytics to help predict credit risk for factoring including what fee should be paid for ACCELERATED PAYMENT. Look at Duecourse.com for an idea that has machine learning. PHD has new fintech growth company characteristics too if they want it to have. | p1nkfish | |
25/4/2018 22:17 | Lewis, and accelerating payments to SME's for a small fee. This sell-off has been exaggerated imho. Some weakness would have been understandable but it reached 95p at one point yesterday and is still well below the placing price today after £3M of cost cuts ALREADY ACHIEVED. | p1nkfish | |
25/4/2018 21:42 | Just to add pink. I work in local government in UK and proactis have a procurement software package which is used by over 500 public sector organisations with its own supplier database of around 500k suppliers last time I checked.Imagine the power of bringing all suppliers together under the business network. | lewis winthorpe | |
25/4/2018 21:33 | I've added in size | aishah | |
25/4/2018 21:22 | Filled my boots. Market cap is now about £108M. They paid approximately £102.4 million for Perfect Commerce. They did an oversubscribed conditional placing to raise £70.0 million at 165 pence per Placing Share. Proactis has over 1000 customers. They now have a business network & Perfect had over 1.3 million users across more than 80 countries, 20 languages and 100 currencies. Perfect Commerce operates its own proprietary supplier network - 'The Business Network' - which has approximately 970,000 suppliers connected to it. Those suppliers are able to use The Business Network to collaborate with and transact efficiently and electronically with their customers. Now add factoring, cost base reduction, cross and up-sell = $$$. Go figure. This is a bump in the road. It will come back meaner and leaner with everything to prove. Can't stand the risk? Please sell. I know people who will buy. 😊 | p1nkfish | |
25/4/2018 20:51 | Don't buy if concerned or can't cope with the risk. As they say in Yorkshire, "if in doubt, do nowt". 1000 customers and 35 new names, there's a market. I'm in, Better if you walk & move on. | p1nkfish | |
25/4/2018 17:38 | I have a small holding now so will be very pleased with 130p but this is definitely high risk, another warning and it will be well below 100p so don't bet the house. | its the oxman | |
25/4/2018 17:32 | pinkfish loss of a few big clients ...'phps PHD not wanting to erode margins' but that is more important than you infer imho if -there is real competition on margins (if a risk of a margin fight its mean lower profits imo & infers there is no moat against competition.... & if more competition is arriving then it normally means smaller margins - & phps questions whether the PHD service (Im thinking of some software based buying & bidding processes) produces the claimed cost savings & benefits; if it did then surely no one would leave Im only stating obvious points imo --- sure the share price might bounce back a bit but could next RNS at 7am make the share price open up a chunky % lower ? from where Im sitting there seem to be various unknowns or concerns; big change since co. news in Feb. | smithie6 | |
25/4/2018 17:20 | I keep reading the rns and still don't understand the drop.No profits warning, gained more customers than lost. Have healthy balance sheet with 28 mill of debt which was known and more than covered by HSBC to the tune of 45 mill.Slight caution on sterling but that's it. | lewis winthorpe | |
25/4/2018 16:59 | What will you pay us if it reaches > 130p, Oxman? "See this going to c.125p at most over the weeks ahead." | p1nkfish | |
25/4/2018 16:56 | Some decent blocks on the buy side. 600k etc Some have been well and truly shaken out. | p1nkfish | |
25/4/2018 16:26 | I am hoping to see some rns's re director purchases over the next few days. | the vampire | |
25/4/2018 15:17 | Worth a wee punt. Bought a few. Seems oversold | volsung | |
25/4/2018 14:55 | See this going to c.125p at most over the weeks ahead. Can't see it any higher without a positive trading update. Risk is obviously that this is just the first installment of a cycle of bad news and further eps reduction. Let's just hope that is not the case and management get their act together running the business, make no more acquisitions and concentrate on paying down the debt. | its the oxman | |
25/4/2018 14:07 | Owenski - cheap. At the time they were saving customers money doing the same. Annual reports were good but wherever they could they avoided any overspend. I like that. | p1nkfish | |
25/4/2018 13:48 | 1461 Smithie, I mean no one knows. 2 losses were down to software vendor consolidation, Shell, BP. The others could haven been down to many different reasons including PHD not wanting to erode margins - an attitude I respect if so. Market has acted as if the sky is falling, selling first and questioning after. They had 35 new signings including large US public sector. The big market for PHD is not oil & gas but will be the business network. It's a buy for me. Recovery will occur once shares are digested. May be slowly. Waiting for recovery means missing the entrance price. | p1nkfish |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions